Found 54 Enz. Inhib. hit(s) with all data for entry = 9686 TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.0750nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.0950nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.117nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.167nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.241nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.268nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.287nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.294nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.324nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.387nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.389nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.392nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.411nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.427nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.430nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.614nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.625nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.634nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.635nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.690nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.703nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.741nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 0.861nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 1.03nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 1.04nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 1.09nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 1.13nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 1.37nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 1.45nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 1.51nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 1.60nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 1.75nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 1.79nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 2nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 2.08nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 2.45nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 2.70nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 2.93nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 3.15nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 3.37nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 3.40nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 3.53nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 5.71nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 6.11nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 9.61nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 11.8nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 29.8nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 53.8nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 56.6nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
TargetProtein O-GlcNAcase(Homo sapiens (Human))
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.
US Patent
Affinity DataKi: 71.2nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
